Being stuck in the house for around a month now, the Egyptian citizens let alone the entire globe is getting quite restless. All places that include any socializing are still shut down plus the curfew in Egypt has been extended for another two weeks to ensure safety.
Which is why, you would be happy to hear that Khaled Abdel Ghaffar, the Minister of Higher Education and Scientific Research, has thankfully found a way to communicate with the Japanese manufacturer of the antiviral drug that is claimed to be the cure against the Coronavirus pandemic.
Avigan, the Japanese drug, has been developed by the Fujifilm Holdings Corporation and has been stored in the country for a while now to treat influenza. It has been proved by reports that Avigan has shown quite effective when treating COVID-19 and fighting the respiratory disease specifically that has been caused by the virus.
Fujifilm Holdings Corporation has announced late last night that it will commence phase two of their clinical trials on patients suffering in the United States since their situation has gotten quite out of hands.
Not just that, but our minister has added that Egypt will be joining this scientific research in hopes of finding a medication to truly put an end to the this cruel pandemic.
The trial will admit 50 coronavirus infected patients in collaboration with the Women’s Hospital, Brigham, and the University of Massachusetts Medical School.
It was also stressed by Dr.Abdel Ghaffar that our President Abdel Fattah el Sisi has crucially instructed a follow up and constant collaboration on a day to day basis with the Japanese Pharmaceutical company to commence manufacturing Avigan in one of the Egyptian pharmaceutical companies located in the City of 10th of Ramadan.
The drug had already been tested on the Japanese citizens when Fujifilm had announced on March 31 the start of phase 3 of the clinical trial.
We would like to thank Japan for offering help to end the global pandemic by willing to provide at least 20 countries with Avigan for free. Not just that, but they will be providing the United Nations Office for Project Services $1 million grant to distribute as well as buy the drug.